Mr Roger Clark

Roger is Head of High Throughput Screening (HTS) within Early Discovery at Charles River Labs (CRL). He has over 20 years’ experience in early drug discovery spending several years with AstraZeneca (in roles spanning HTS to late-stage profiling of molecules for candidate selection) before joining CRL in 2018. His current remit sees him leading CRL’s HTS department across UK & NL, delivering assay development and execution of molecular target-based and phenotypic Hit ID campaigns for multiple client projects.